Literature DB >> 9860002

Reperfusion of occluded capillary beds in diabetic retinopathy.

K Takahashi1, S Kishi, K Muraoka, K Shimizu.   

Abstract

PURPOSE: To demonstrate the reperfusion of nonperfused capillary beds in diabetic retinopathy.
METHODS: In a retrospective study, we reviewed 292 fluorescein angiograms of 94 eyes of 74 patients (mean age, 52 years; range, 20 to 68 years) with diabetic retinopathy. Fluorescein angiography was performed repeatedly (mean, three times; range, two to eight times) during a mean follow-up period of 2 years (range, 3 months to 12 years). None of the 94 eyes received laser photocoagulation.
RESULTS: Reperfusion of occluded capillary beds was observed in 65 (69%) of 94 eyes. Reperfusion was characterized by recanalization in 22 (34%) of the 65 eyes or by intraretinal neovascularization in 54 (83%) of the 65 eyes. The former took place in small nonperfused areas and the latter in larger nonperfused areas. Reperfusion occurred throughout the entire fundus in six of 94 eyes, resulting in resolution of diabetic retinopathy. Reperfused capillary beds with intraretinal neovascularization left vascular remodeling, which was seen as twisted or kinked abnormal vessels.
CONCLUSIONS: In diabetic retinopathy, occluded capillary beds may be reperfused. Twisted abnormal vessels may represent the reperfusion process through intraretinal neovascularization.

Entities:  

Mesh:

Year:  1998        PMID: 9860002     DOI: 10.1016/s0002-9394(98)00242-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Retinal non-perfusion in diabetic retinopathy.

Authors:  Charles C Wykoff; Hannah J Yu; Robert L Avery; Justis P Ehlers; Ramin Tadayoni; SriniVas R Sadda
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 3.775

Review 3.  Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.

Authors:  Irini Chatziralli; Sara Touhami; Maria Vittoria Cicinelli; Chrysa Agapitou; Eleni Dimitriou; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Eye (Lond)       Date:  2021-08-18       Impact factor: 3.775

4.  Managing patients with retinal vein occlusions: is there any real step forward?

Authors:  S Natarajan
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

5.  Expounding newer vistas in VEGF.

Authors:  Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2013 Jan-Feb       Impact factor: 1.848

Review 6.  Current understanding of the molecular and cellular pathology of diabetic retinopathy.

Authors:  David A Antonetti; Paolo S Silva; Alan W Stitt
Journal:  Nat Rev Endocrinol       Date:  2021-01-19       Impact factor: 47.564

Review 7.  Endothelial progenitor cells in diabetic retinopathy.

Authors:  Noemi Lois; Rachel V McCarter; Christina O'Neill; Reinhold J Medina; Alan W Stitt
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-09       Impact factor: 5.555

8.  Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.

Authors:  Alexander A Veenstra; Jie Tang; Timothy S Kern
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

9.  Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections.

Authors:  Ariana M Levin; Irene Rusu; Anton Orlin; Mrinali P Gupta; Peter Coombs; Donald J D'Amico; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2017-01-21

10.  Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography.

Authors:  Osama A Sorour; Nihaal Mehta; Caroline R Baumal; Akihiro Ishibazawa; Keke Liu; Eleni K Konstantinou; Sarah Martin; Phillip Braun; A Yasin Alibhai; Malvika Arya; Andre J Witkin; Jay S Duker; Nadia K Waheed
Journal:  Eye Vis (Lond)       Date:  2020-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.